Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes
Clinical trial NCT01302106 · WITHDRAWN
Trial details
- NCT number
- NCT01302106
- Sponsor
- Fondazione Italiana Sindromi Mielodisplastiche-ETS
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.